MeiraGTx Holdings
Latest round
- Series B
Last raised
- Jun 2017
Total raised
- $50M
Investors
- 1
About MeiraGTx Holdings
MeiraGTx Holdings plc is a biotechnology firm founded in 2015, headquartered in New York, US.MeiraGTx provides advanced genetic medicine solutions, such as its proprietary riboswitch gene regulation platform, which offers unique control over gene expression. This technology is aimed at treating various inherited diseases, with a focus on improving patient outcomes.07 mn.Looking ahead, MeiraGTx is focused on launching new genetic therapy products designed to target specific conditions in patients, with plans for market introductions in North America and Europe by 2025.00 mn is earmarked for expanding its research and development initiatives, enhancing its product offerings, and bolstering its presence in existing and new markets. The company aims to solidify its position in the genetic medicine landscape through strategic collaborations and innovative solutions.
Who invested in MeiraGTx Holdings
1 investor across 1 round
See all investors in MeiraGTx Holdings
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jun 1, 2017
Amount
$50M
Investors
Questions about MeiraGTx Holdings
Who invested in MeiraGTx Holdings?
MeiraGTx Holdings has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MeiraGTx Holdings raised?
MeiraGTx Holdings has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did MeiraGTx Holdings last raise money?
MeiraGTx Holdings's most recent round on record is a Series B, in Jun 2017.
What does MeiraGTx Holdings do?
MeiraGTx Holdings plc is a biotechnology firm founded in 2015, headquartered in New York, US.
Where is MeiraGTx Holdings headquartered?
MeiraGTx Holdings is headquartered in New York, US.
Which VCs invest in companies like MeiraGTx Holdings?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at MeiraGTx Holdings's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like MeiraGTx Holdings? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.